Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglial TNF‐α mediates enhancement of dopaminergic degeneration by brain angiotensin
Ana Borrajo, Ana I. Rodríguez‐Pérez, Carmen Díaz-Ruiz, et al.
Glia (2013) Vol. 62, Iss. 1, pp. 145-157
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
José L. Labandeira‐García, Ana I. Rodríguez‐Pérez, Pablo Garrido‐Gil, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 206
ROCK inhibition in models of neurodegeneration and its potential for clinical translation
Jan Christoph Koch, Lars Tatenhorst, Anna‐Elisa Roser, et al.
Pharmacology & Therapeutics (2018) Vol. 189, pp. 1-21
Open Access | Times Cited: 190
The renin–angiotensin system: a possible new target for depression
João Vian, C. Lopes Pereira, V. Chavarría, et al.
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 118
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Çağlar Coşarderelioğlu, Lolita S. Nidadavolu, Claudene J. George, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 108
Brain renin-angiotensin system and dopaminergic cell vulnerability
José L. Labandeira‐García, Pablo Garrido‐Gil, Jannette Rodríguez‐Pallares, et al.
Frontiers in Neuroanatomy (2014) Vol. 8
Open Access | Times Cited: 100
Brain region-specific gene expression profiles in freshly isolated rat microglia
Karlijn J. Doorn, John J. P. Brevé, Benjamin Drukarch, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 99
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Antonio Dominguez‐Meijide, Ana I. Rodríguez‐Pérez, Carmen Díaz-Ruiz, et al.
Brain Behavior and Immunity (2017) Vol. 62, pp. 277-290
Closed Access | Times Cited: 89
Interaction between NADPH‐oxidase and Rho‐kinase in angiotensin II‐induced microglial activation
Ana I. Rodríguez‐Pérez, Ana Borrajo, Jannette Rodríguez‐Pallares, et al.
Glia (2014) Vol. 63, Iss. 3, pp. 466-482
Closed Access | Times Cited: 88
Beneficial effects of Angiotensin II receptor blockers in brain disorders
Juan M. Saavedra
Pharmacological Research (2017) Vol. 125, pp. 91-103
Closed Access | Times Cited: 74
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Ana I. Rodríguez‐Pérez, Diego Sucunza, María A. Pedrosa, et al.
Neurotherapeutics (2018) Vol. 15, Iss. 4, pp. 1063-1081
Open Access | Times Cited: 74
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
Ana Borrajo, Ana I. Rodríguez‐Pérez, Begoña Villar‐Cheda, et al.
Neuropharmacology (2014) Vol. 85, pp. 1-8
Closed Access | Times Cited: 71
Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anna‐Elisa Roser, Lars Tönges, Paul Lingor
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 66
Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia
Jinbo Cheng, Yajin Liao, Lei Xiao, et al.
Cell Death and Differentiation (2016) Vol. 24, Iss. 2, pp. 276-287
Open Access | Times Cited: 63
Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
Ana I. Rodríguez‐Pérez, Pablo Garrido‐Gil, María A. Pedrosa, et al.
Brain Behavior and Immunity (2019) Vol. 87, pp. 256-271
Closed Access | Times Cited: 63
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
Carmen M. Labandeira, María A. Pedrosa, Aloia Quijano, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Apigenin Attenuates Hippocampal Microglial Activation and Restores Cognitive Function in Methotrexate-Treated Rats: Targeting the miR-15a/ROCK-1/ERK1/2 Pathway
Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3770-3787
Open Access | Times Cited: 18
The role of the brain renin-angiotensin system in Parkinson´s disease
José L. Labandeira‐García, Carmen M. Labandeira, María J. Guerra, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β
Ana Muñoz, Pablo Garrido‐Gil, Antonio Dominguez‐Meijide, et al.
Experimental Neurology (2014) Vol. 261, pp. 720-732
Closed Access | Times Cited: 62
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
Santiago Perez‐Lloret, Matilde Otero‐Losada, Jorge E. Toblli, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 10, pp. 1163-1173
Open Access | Times Cited: 58
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
Ana I. Rodríguez‐Pérez, Ana Borrajo, Carmen Díaz-Ruiz, et al.
Oncotarget (2016) Vol. 7, Iss. 21, pp. 30049-30067
Open Access | Times Cited: 57
The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives
Parneet Kaur, Arunachalam Muthuraman, Manjinder Kaur
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 508-521
Closed Access | Times Cited: 55
Menopause and Parkinson’s disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration
José L. Labandeira‐García, Ana I. Rodríguez‐Pérez, Rita Valenzuela, et al.
Frontiers in Neuroendocrinology (2016) Vol. 43, pp. 44-59
Closed Access | Times Cited: 55
Gamma subunit of complement component 8 is a neuroinflammation inhibitor
Jong‐Heon Kim, Ruqayya Afridi, Jin Han, et al.
Brain (2020) Vol. 144, Iss. 2, pp. 528-552
Open Access | Times Cited: 41
NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
Juan A. Parga, Ana I. Rodríguez‐Pérez, María García-Garrote, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1649-1649
Open Access | Times Cited: 34
Serum inflammatory cytokines levels and the correlation analyses in Parkinson’s disease
Jiajia Fu, Sihui Chen, Jiao Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top